Andreas Schnitzbauer
Andreas Schnitzbauer
Universitätsklinikum Frankfurt, Goethe Universität Frankfurt am Main
Verified email at
Cited by
Cited by
Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for …
AA Schnitzbauer, SA Lang, H Goessmann, S Nadalin, J Baumgart, ...
Annals of surgery 255 (3), 405-414, 2012
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study
D Nepogodiev, A Bhangu, JC Glasbey, E Li, OM Omar, JFF Simoes, ...
The Lancet 396 (10243), 27-38, 2020
Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans
Journal of British Surgery 107 (11), 1440-1449, 2020
Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services
K Søreide, J Hallet, JB Matthews, AA Schnitzbauer, PD Line, PBS Lai, ...
Journal of British Surgery 107 (10), 1250-1261, 2020
Early survival and safety of ALPPS: first report of the International ALPPS Registry
E Schadde, V Ardiles, R Robles-Campos, M Malago, M Machado, ...
Annals of surgery 260 (5), 829-838, 2014
Sirolimus use in liver transplant recipients with hepatocellular carcinoma: a randomized, multicenter, open-label phase 3 trial
EK Geissler, AA Schnitzbauer, C Zülke, PE Lamby, A Proneth, C Duvoux, ...
Transplantation 100 (1), 116, 2016
Prediction of mortality after ALPPS Stage-1
E Schadde, DA Raptis, AA Schnitzbauer, V Ardiles, C Tschuor, M Lesurtel, ...
Annals of surgery 262 (5), 780-786, 2015
A randomized, controlled study to assess the conversion from calcineurin‐inhibitors to everolimus after liver transplantation—PROTECT
L Fischer, J Klempnauer, S Beckebaum, HJ Metselaar, P Neuhaus, ...
American Journal of Transplantation 12 (7), 1855-1865, 2012
Serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetes
J Weigert, M Neumeier, J Wanninger, S Bauer, S Farkas, MN Scherer, ...
The Journal of Clinical Endocrinology & Metabolism 95 (3), 1404-1411, 2010
Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study
F Saliba, P De Simone, F Nevens, L De Carlis, HJ Metselaar, ...
American journal of transplantation 13 (7), 1734-1745, 2013
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for …
AA Schnitzbauer, C Zuelke, C Graeb, J Rochon, I Bilbao, P Burra, ...
BMC cancer 10 (1), 1-8, 2010
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study
COVIDSurg Collaborative, GlobalSurg Collaborative, D Nepogodiev, ...
Anaesthesia 76 (6), 748-758, 2021
Patient blood management is associated with a substantial reduction of red blood cell utilization and safe for patient's outcome
P Meybohm, E Herrmann, AU Steinbicker, M Wittmann, M Gruenewald, ...
Annals of surgery 264 (2), 203-211, 2016
Systematic review and meta-analysis of feasibility, safety, and efficacy of a novel procedure: associating liver partition and portal vein ligation for staged hepatectomy
E Schadde, AA Schnitzbauer, C Tschuor, DA Raptis, WO Bechstein, ...
Annals of surgical oncology 22 (9), 3109-3120, 2015
Calcineurin inhibitor minimization protocols in liver transplantation
SA Farkas, AA Schnitzbauer, G Kirchner, A Obed, B Banas, HJ Schlitt
Transplant international 22 (1), 49-60, 2009
Bile duct damage after cold storage of deceased donor livers predicts biliary complications after liver transplantation
SM Brunner, H Junger, P Ruemmele, AA Schnitzbauer, A Doenecke, ...
Journal of Hepatology 58 (6), 1133-1139, 2013
Mortality after liver surgery in Germany
N Filmann, D Walter, E Schadde, C Bruns, T Keck, H Lang, K Oldhafer, ...
Journal of British Surgery 106 (11), 1523-1529, 2019
Delaying surgery for patients with a previous SARS-CoV-2 infection
Journal of British Surgery 107 (12), e601-e602, 2020
Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation--a phase I study (MISOT-I)
FC Popp, B Fillenberg, E Eggenhofer, P Renner, J Dillmann, V Benseler, ...
Journal of translational medicine 9 (1), 1-10, 2011
Small-interference RNA-mediated knock-down of aldehyde oxidase 1 in 3T3-L1 cells impairs adipogenesis and adiponectin release
J Weigert, M Neumeier, S Bauer, W Mages, AA Schnitzbauer, A Obed, ...
FEBS letters 582 (19), 2965-2972, 2008
The system can't perform the operation now. Try again later.
Articles 1–20